SEC Form 10-K Summary
Filing identity: The supplied filing is for Tuscan Holdings Corp. (THCB), not Microvast Holdings, Inc. Investors should verify that this is the intended filing.
Business Context and Reporting Period
The filing covers the year ended December 31, 2019, with quarterly information for the fourth quarter of 2019. Tuscan was a blank check company formed on November 5, 2018, to pursue an initial business combination. It had no operating business or revenue and was focusing its search primarily on the cannabis industry, although its mandate was broader.
The company completed its initial public offering in March 2019, raising $276.0 million in aggregate IPO and private-placement proceeds that were placed in a trust account. No target business had been identified as of December 31, 2019.
Financial Performance and Position
| Metric | Year ended December 31, 2019 | Prior comparable period |
|---|---|---|
| Operating revenue | None; the company had no operating business | None |
| Loss from operations | $(778,815) | $(792) for the period from inception through December 31, 2018 |
| Interest income | $4,912,346 | — |
| Unrealized gain on trust-account securities | $128,899 | — |
| Net income (loss) | $3,367,179 | $(792) |
| Basic and diluted loss per share | $(0.07) | $(0.00) |
| Cash | $140,303 | $17,500 |
| Trust-account securities | $280,103,245 | — |
| Total assets | $280,499,613 | $101,200 |
| Total liabilities | $296,124 | $75,792 |
| Common stock subject to possible redemption | $275,203,480 | — |
| Stockholders’ equity | $5,000,009 | $25,408 |
Net income was primarily generated by interest and unrealized gains on trust-account investments rather than business operations. The company reported no operating margin because it had no operating revenue. Cash used in operating activities was $1,634,432. Net cash used in investing activities was $275,062,000, principally reflecting the funding of the trust account, partly offset by $938,000 withdrawn to pay income taxes. Cash at year-end was $140,303.
The company had no long-term debt, capital leases, operating leases, or other long-term liabilities reported. It had a $10,000 monthly administrative-services arrangement with an affiliate of the chief executive officer and incurred $100,000 under that arrangement during 2019.
Material Changes Versus the Prior Comparable Period
- The company completed its IPO and over-allotment offering in March 2019, issuing 27.6 million public units and raising gross proceeds of $276.0 million, plus $6.87 million from private units.
- Trust-account securities increased from zero to $280.1 million, including accrued interest and unrealized gains.
- Operating expenses increased from $792 for the 2018 inception period to $778,815 in 2019 as the company became a public entity and pursued acquisition opportunities.
- Net income of $3.37 million in 2019 contrasted with a $792 net loss in the 2018 inception period; the change was attributable to trust-account investment income.
- Common stock subject to possible redemption totaled $275.2 million at year-end, representing 27,126,477 redeemable shares.
- Fourth-quarter 2019 operating costs were $251,152, interest income was $1,254,820, unrealized gains were $163,993, and net income was $922,451.
Guidance, Outlook, Risks and Unusual Items
Management did not provide operating revenue, earnings, or financial guidance. The company expected no operating revenue until after completion of a business combination.
- The company was required to complete a business combination by December 7, 2020. If unsuccessful, it would redeem the public shares and liquidate, subject to creditor claims and applicable law.
- Public stockholders could generally redeem their shares for a pro rata portion of the trust account in connection with a business combination or liquidation. Warrants would receive no liquidation distribution and could expire worthless.
- The target business was required to have a fair market value of at least 80% of the trust-account balance, subject to the conditions described in the filing, and the post-transaction company generally had to obtain a controlling interest.
- Potential funding shortfalls could require additional debt or equity financing, resulting in dilution or increased leverage. Up to $1.5 million of working-capital loans could be converted into private units.
- Trust-account proceeds could be reduced by creditor claims, bankruptcy proceedings, or unenforceable waivers. Although the sponsor agreed to provide certain indemnification, the filing stated that the sponsor might not have sufficient assets to satisfy those obligations.
- Key risks included the absence of an identified target, limited operating history, acquisition and valuation uncertainty, conflicts of interest, sponsor influence, warrant dilution, Nasdaq delisting, and dependence on a single eventual business.
- Because the company was considering cannabis-related targets, it highlighted federal illegality under the Controlled Substances Act, regulatory uncertainty, banking limitations, potential contract-enforceability issues, tax consequences under Section 280E, and possible exchange-listing restrictions.
- The filing also identified the COVID-19 outbreak as a potential impediment to travel, negotiations, financing, and completion of a business combination.
Important Facts for Investors to Verify
- Confirm whether the filing should be attributed to Tuscan Holdings Corp. or Microvast Holdings, Inc.; the supplied document identifies Tuscan throughout.
- Verify the amount and composition of trust-account assets, including the $280.1 million balance and tax withdrawals.
- Review the redemption terms, December 7, 2020 liquidation deadline, and the potential for distributions below $10.00 per share.
- Assess sponsor, management, and affiliate conflicts, including the 21% sponsor ownership and the $10,000 monthly affiliate-services fee.
- Evaluate dilution from 28.287 million public and private warrants, additional financing, and potential conversion of working-capital loans.
- Confirm whether any business combination was subsequently announced or completed after the December 31, 2019 reporting date.
- Review the audited financial statements and notes for redemption classification, trust-account restrictions, creditor claims, and contingent obligations.